Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310804
Status:
COMPLETED
Last Update Posted:
2019-08-15
First Post:
2006-04-03
Brief Title:
Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-derived Subunit Influenza Vaccine in Healthy Adults 18 to 60
Sponsor:
Novartis Vaccines
Organization:
Novartis